websensei

websensei

The Case for Newborn Screening in South Africa

Prof. Chris Vorster, a chemical pathologist at the North-West University’s Centre for Human Metabolomics (NWU-CHM), has spent over 15 years in clinical diagnostics and metabolic diseases. His experience has led him to strongly advocate for the implementation of a national…

NMP Team Member Attends Prestigious Metabolomics Course

Ms. Elmarie Davoren, Principal Investigator at the National Metabolomics Platform (NMP), was recently chosen as one of a select few to attend a 5-day course on quantitative metabolite measurement for clinical metabolomics at The Metabolomics Innovation Centre (TMIC) in Canada.…

Unravelling the Mysteries of Tuberculosis Treatment

Tuberculosis (TB) remains a formidable challenge in developing countries, and the complexities of its treatment continue to baffle researchers. Dr. Monique Opperman (née Combrink), a post-doctoral fellow at the NWU Centre for Human Metabolomics, has been at the forefront of…

accelRare® is a pre-diagnostic solution for rare diseases. accelRare® uses the medvir tool, certified as a Class I medical device, for which Medical Intelligence Service is the manufacturer and Sanofi the distributor.

Receive the Form with PDF Attachment

To obtain a copy of this form as PDF attachment for printing, please provide your email address below.

Provide clinical information

Clinical information may greatly assist in the interpretation of metabolic results and additional recommendations. The clinical information can be provided here

Print the test selection form from email and hand to the patient or phlebotomist for sample collection

[field id="reference_id"]
[field id="imdclinicalresult1"]

The National Metabolomics Platform is a specialized laboratory dedicated to diagnosing rare and inherited metabolic diseases. Located on the Potchefstroom campus of North-West University, the laboratory may occasionally require additional tests, including genetic testing, to confirm a diagnosis. If these tests incur additional costs, the laboratory will seek prior approval from you and/or your clinician. To ensure diagnostic accuracy, clinical information and other reports may also be requested. Such requests are made solely to enhance the precision of the diagnosis. Following a diagnosis, the laboratory may contact you about potential research projects for which you might be eligible. These projects aim to improve the understanding and characterization of rare diseases and offer patients opportunities to participate in international clinical trials. Participation in these projects is entirely voluntary, and there is no obligation to take part if contacted. All research is conducted under the oversight of the NWU Health Research Ethics Committee.

GCxGC-TOFMS Untargeted

Compound list

Spectra identified via comparison with library spectra

NMR Untargeted

Compound list

Spectra identified via comparison with library spectra

LDL Cholesterol Subfractions

Compound list

The LDL subfraction test measures up to twelve lipoprotein fractions and subfractions (VLDL, mid-bands A-C and LDL 1 through 7)

HDL Cholesterol Subfractions

Compound list

Separates and quantifies up to 10 HDL subfractions, classified from large buoyant HDL lipoproteins (HDL-L) to small-dense HDL lipoproteins (HDL-S).